Peptaibol-Containing Extracts of


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
04 Oct 2021
Historique:
received: 06 09 2021
revised: 26 09 2021
accepted: 29 09 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 15 12 2021
Statut: epublish

Résumé

Fighting resistance to antibiotics and chemotherapeutics has brought bioactive peptides to the fore. Peptaibols are short α-aminoisobutyric acid-containing peptides produced by

Identifiants

pubmed: 34641569
pii: molecules26196025
doi: 10.3390/molecules26196025
pmc: PMC8512731
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antineoplastic Agents 0
Fungal Proteins 0
Peptaibols 0
Ligases EC 6.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Grant Agency of Ministry of Education, Science, Research and Sport of the Slovak Republic
ID : VEGA-1/0697/18
Organisme : International Visegrad Fund
ID : 22010090

Références

Biopolymers. 2017 Nov 11;:
pubmed: 29127716
Biochim Biophys Acta. 2016 Sep;1858(9):2231-2244
pubmed: 27368477
Eukaryot Cell. 2007 Dec;6(12):2332-42
pubmed: 17933910
Vet Res. 2014 Mar 19;45:31
pubmed: 24641543
Mol Pharm. 2010 Dec 6;7(6):2334-48
pubmed: 20958074
Chem Biodivers. 2015 May;12(5):743-51
pubmed: 26010663
Microbiology (Reading). 2007 Oct;153(Pt 10):3417-3437
pubmed: 17906141
AMB Express. 2020 Nov 11;10(1):204
pubmed: 33175275
Biomolecules. 2020 May 07;10(5):
pubmed: 32392805
BMC Genomics. 2013 Feb 22;14:121
pubmed: 23432824
Annu Rev Phytopathol. 2013;51:105-29
pubmed: 23915132
Bioorg Med Chem Lett. 2020 Jun 1;30(11):127135
pubmed: 32229061
Mol Cell Biochem. 2013 Feb;374(1-2):223-32
pubmed: 23180247
Int J Mol Sci. 2018 Dec 04;19(12):
pubmed: 30518103
Cell Cycle. 2018;17(13):1649-1666
pubmed: 29963969
Toxicol Appl Pharmacol. 2016 Nov 1;310:215-228
pubmed: 27664577
Front Microbiol. 2019 Jun 26;10:1434
pubmed: 31293557
RSC Adv. 2017;7(72):45733-45751
pubmed: 29379602
Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2789-98
pubmed: 26248014
Drug Resist Updat. 2016 May;26:43-57
pubmed: 27180309
J Photochem Photobiol B. 2018 Apr;181:150-156
pubmed: 29567316
Oncotarget. 2017 Jul 11;8(28):46635-46651
pubmed: 28422728
Molecules. 2020 Jun 19;25(12):
pubmed: 32575664
J Bioenerg Biomembr. 2020 Oct;52(5):321-342
pubmed: 32715369
Appl Environ Microbiol. 2004 Aug;70(8):4996-5004
pubmed: 15294840
Chem Biodivers. 2007 Jun;4(6):1027-51
pubmed: 17589875
Cancer Treat Rev. 2017 Jan;52:48-57
pubmed: 27889637
Springerplus. 2014 Oct 13;3:600
pubmed: 25392773
Toxicol Appl Pharmacol. 2018 May 15;347:79-91
pubmed: 29625142
J Pept Sci. 2009 Dec;15(12):799-807
pubmed: 19827002
Molecules. 2020 May 12;25(10):
pubmed: 32408616
PLoS One. 2018 Apr 30;13(4):e0193872
pubmed: 29708970
J Fungi (Basel). 2017 Aug 26;3(3):
pubmed: 29371563
Colloids Surf B Biointerfaces. 2014 Apr 1;116:472-81
pubmed: 24561501
Int J Mol Sci. 2017 Nov 08;18(11):
pubmed: 29117122
Annu Rev Microbiol. 2014;68:81-100
pubmed: 24819367
Curr Genet. 2008 Dec;54(6):283-99
pubmed: 18836726
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1686-98
pubmed: 24055719
Nat Rev Microbiol. 2019 Mar;17(3):167-180
pubmed: 30531948
Fungal Genet Biol. 2007 Nov;44(11):1123-33
pubmed: 17509915
Mol Cancer. 2010 Feb 02;9:26
pubmed: 20122248
Int J Mol Sci. 2019 Nov 14;20(22):
pubmed: 31739573
Front Microbiol. 2013 Oct 01;4:294
pubmed: 24101917
Lancet Infect Dis. 2016 Feb;16(2):147-9
pubmed: 26711361
Biochim Biophys Acta. 2015 Nov;1848(11 Pt B):3078-88
pubmed: 25724815
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nat Rev Microbiol. 2004 Jan;2(1):43-56
pubmed: 15035008
Chem Pharm Bull (Tokyo). 1995 Oct;43(10):1663-7
pubmed: 8536339
One Health. 2015 Dec 12;2:11-17
pubmed: 28616471
Front Cell Infect Microbiol. 2016 Dec 27;6:194
pubmed: 28083516
BMC Microbiol. 2019 May 16;19(1):98
pubmed: 31096902
PLoS Pathog. 2021 Jan 14;17(1):e1009172
pubmed: 33444399

Auteurs

Ján Víglaš (J)

Institute of Biochemistry and Microbiology, Faculty of Food and Chemical Technology, Slovak University of Technology in Bratislava, 812 37 Bratislava, Slovakia.

Simona Dobiasová (S)

Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.

Jitka Viktorová (J)

Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.

Tomáš Ruml (T)

Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic.

Vanda Repiská (V)

Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.

Petra Olejníková (P)

Institute of Biochemistry and Microbiology, Faculty of Food and Chemical Technology, Slovak University of Technology in Bratislava, 812 37 Bratislava, Slovakia.

Helena Gbelcová (H)

Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH